NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)

Clinical trials for NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) explained in plain language.

Never miss a new study

Get alerted when new NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) trials appear

Sign up with your email to follow new studies for NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 5 Not yet recruiting 1 Not yet finished but already full! 6 Completed 2

Diabetes drug vs cholesterol meds: new battle for liver health

Disease control Not yet recruiting

This study compares two types of medications—empagliflozin (a diabetes drug) and statins (cholesterol medications)—to see which works better for treating fatty liver disease. Researchers will enroll 400 adults who have fatty liver disease along with obesity, diabetes, and high ch…

Matched conditions: NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)

Phase: PHASE4 • Sponsor: Badr University • Aim: Disease control

Last updated Mar 20, 2026 14:48 UTC

NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)

Get alerted when new NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) trials appear

Diabetes drug vs cholesterol meds: new battle for liver health